Form Type: 4

SEC EDGAR Link
Accession Number:0001223203-19-000035
Date:2019-05-08
Issuer: EDWARDS LIFESCIENCES CORP (EW)
Original Submission Date:

Reporting Person:

WANG HUIMIN
C/O EDWARDS LIFESCIENCES
ONE EDWARDS WAY IRVINE, CA 92614

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-05-08 A 1,075 a $0.00 32,396 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO ACQUIRE) 177.77 2019-05-08 deemed execution date A 10,600 (a) 2019-06-08 2026-05-07 common stock 10,600 $177.77 10,600 direct
PERFORMANCE RIGHTS 0.0 2019-05-08 deemed execution date A 1,325 (a) 2022-05-08 2026-05-07 common stock 1,325 $0.00 1,325 direct
Footnotes
IDfootnote
f1 these restricted stock units were granted on may 8, 2019 under the edwards lifesciences corporation long-term stock incentive compensation program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date.
f2 these options were granted on may 8, 2019 under the edwards lifesciences corporation long-term stock incentive compensation program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal annual installments.
f3 reflects the target number of shares (the target award) covered by restricted stock units granted under the edwards lifesciences corporation long-term stock incentive compensation program on may 8, 2019 and scheduled to vest on may 8, 2022. the number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the target awards.
WhaleWisdom Logo

Elevate your investments